These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24837642)

  • 21. Hypersexuality and paraphilia induced by selegiline in Parkinson's disease: report of 2 cases.
    Shapiro MA; Chang YL; Munson SK; Okun MS; Fernandez HH
    Parkinsonism Relat Disord; 2006 Sep; 12(6):392-5. PubMed ID: 16730214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the safety and tolerability of rasagiline in the treatment of the early stages of Parkinson's disease.
    Viallet F; Pitel S; Lancrenon S; Blin O
    Curr Med Res Opin; 2013 Jan; 29(1):23-31. PubMed ID: 23176073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
    Chen JJ; Swope DM; Dashtipour K
    Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.
    Rascol O; Brooks DJ; Melamed E; Oertel W; Poewe W; Stocchi F; Tolosa E;
    Lancet; 2005 Mar 12-18; 365(9463):947-54. PubMed ID: 15766996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term efficacy of rasagiline in early Parkinson's disease.
    Lew MF; Hauser RA; Hurtig HI; Ondo WG; Wojcieszek J; Goren T; Fitzer-Attas CJ
    Int J Neurosci; 2010 Jun; 120(6):404-8. PubMed ID: 20504210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rasagiline for motor complications in Parkinson's disease.
    Clarke CE
    Lancet; 2005 Mar 12-18; 365(9463):914-6. PubMed ID: 15766976
    [No Abstract]   [Full Text] [Related]  

  • 27. Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.
    Guay DR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):330-46. PubMed ID: 17296539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic/pharmacodynamic evaluation of rasagiline mesylate for Parkinson's disease.
    Müller T
    Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1423-32. PubMed ID: 25196265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-Associated Spontaneous Orgasm: A Case Report and Systematic Review of Literature.
    Chen WH; Chu YH; Chen KY
    Clin Neuropharmacol; 2018; 41(1):31-37. PubMed ID: 29194112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MAO-B inhibitor know-how: back to the pharm.
    Lewitt PA
    Neurology; 2009 Apr; 72(15):1352-7. PubMed ID: 19365057
    [No Abstract]   [Full Text] [Related]  

  • 31. [Rasagiline in monotherapy in patients with early stages of Parkinson's disease and in combined and adjunct therapy to levodopa with moderate and advanced stages].
    Pagonabarraga J; Rodríguez-Oroz MC
    Rev Neurol; 2013 Jan; 56(1):25-34. PubMed ID: 23250679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
    Parkinson Study Group
    Arch Neurol; 2005 Feb; 62(2):241-8. PubMed ID: 15710852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous remission of MAOI-induced anorgasmia.
    Nathan SG
    Am J Psychiatry; 1988 Jan; 145(1):134-5. PubMed ID: 3337286
    [No Abstract]   [Full Text] [Related]  

  • 34. Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients.
    Brusa L; Musco S; Bernardi G; Iani C; Pierantozzi M; Stanzione P; Stefani A; Finazzi Agro' E
    Parkinsonism Relat Disord; 2014 Aug; 20(8):931-2. PubMed ID: 24861661
    [No Abstract]   [Full Text] [Related]  

  • 35. Bupropion-SR-induced increased libido and spontaneous orgasm.
    Labbate LA
    Can J Psychiatry; 1998 Aug; 43(6):644-5. PubMed ID: 9729695
    [No Abstract]   [Full Text] [Related]  

  • 36. Three cases of impulse control disorder in Parkinson's disease patients receiving dopamine replacement therapy.
    Wilson L; Sheehan J; Thorpe M
    Ir Med J; 2013 Jan; 106(1):24-5. PubMed ID: 23472375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MAOI-induced inhibited female orgasm.
    Shen WW; Mallya AR
    Am J Psychiatry; 1983 Sep; 140(9):1275. PubMed ID: 6614264
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypnotherapy for persistent genital arousal disorder: a case study.
    Elkins GR; Ramsey D; Yu Y
    Int J Clin Exp Hypn; 2014; 62(2):215-23. PubMed ID: 24568327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoxetine-induced sexual dysfunction.
    Herman JB; Brotman AW; Pollack MH; Falk WE; Biederman J; Rosenbaum JF
    J Clin Psychiatry; 1990 Jan; 51(1):25-7. PubMed ID: 2295587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spontaneous remission of MAOI-induced anorgasmia.
    Nurnberg HG; Levine PE
    Am J Psychiatry; 1987 Jun; 144(6):805-7. PubMed ID: 3592004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.